Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Circulating steroid hormones and the risk of prostate cancerSeveri, G.; Morris, H.; MacInnes, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
20075 α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopeciaHayes, V.; Severi, G.; Padilla, E.; Morris, H.; Tilley, W.; Southey, M.; English, D.; Sutherland, R.; Hopper, J.; Boyle, P.; Giles, G.
2008Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potentialRicciardelli, C.; Jackson, M.; Choong, C.; Stahl, J.; Marshall, V.; Horsfall, D.; Tilley, W.
2003ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancerSeveri, G.; Giles, G.; Southey, M.; Tesoriero, A.; Tilley, W.; Neufing, P.; Morris, H.; English, D.; McCredie, M.; Boyle, P.; Hopper, J.
2004Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancerSuwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
2006Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancerSeveri, G.; Morris, H.; MacInnis, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
2007Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancerBaglietto, L.; English, D.; Hopper, J.; Morris, H.; Tilley, W.; Giles, G.
2006Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSASeveri, G.; Hayes, V.; Neufing, P.; Padilla, E.; Tilley, W.; Eggleton, S.; Morris, H.; English, D.; Southey, M.; Hopper, J.; Sutherland, R.; Boyle, P.; Giles, G.